Skip to content

About

Built by an IMG, for IMGs.

Zyntra exists because the path from overseas medical degree to Australian hospital job is harder and less clear than it should be.

Our story

From candidate to founder

Zyntra was built by an International Medical Graduate who went through the same AMC journey as the doctors it now serves.

After clearing the AMC MCQ in May 2025 with a score of 321/500, and now beginning PGY1 in Sydney, the founder saw first-hand that the hardest parts weren’t always the medicine. Time pressure, second-guessing and composure on the day decided outcomes. After the exam, a confusing maze of pathways, CV conventions and job applications held capable doctors back.

Zyntra brings both halves together: exam preparation that trains how you perform, and career intelligence that shows you exactly what stands between you and your first Australian job.

What we believe

Honest guidance

We tell you what’s actually required — even when it’s not what you want to hear. No inflated promises.

Performance, not just content

Knowledge is necessary but not sufficient. We train the behaviours that decide exam day.

The whole journey

From your first MCQ to your first Australian job, in one connected platform.

Contact

Talk to us

Questions about the platform, partnerships or your account? Email us and we’ll get back to you.

heisenberg@zyntrahealthcareintelligence.com

Important

Zyntra is not affiliated with, endorsed by, or connected to the Australian Medical Council (AMC), AHPRA, or the Medical Board of Australia.

For official information on assessment, registration and eligibility, refer directly to the AMC, AHPRA and the Medical Board of Australia.

Early access

Be one of the first IMGs on the full journey.

We’re onboarding early users and shaping the roadmap with them. Join the early-access list for launch updates, new features and founding-user offers. No spam — unsubscribe any time.

Before you join: 6 quick questions.

We record your answers and how you answer (timing and answer changes) to decide beta selection. We don’t use third-party trackers. See our Privacy Policy.